FHIR IG analytics| Package | hl7.fhir.uv.ebm |
| Resource Type | Group |
| Id | Group-265092.json |
| FHIR Version | R6 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
{
"resourceType": "Group",
"id": "265092",
"meta": {
"versionId": "5",
"lastUpdated": "2025-03-15T21:02:00.141Z",
"profile": [
"http://hl7.org/fhir/uv/ebm/StructureDefinition/conceptual-cohort-definition"
]
},
"language": "en",
"text": {
"status": "empty",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail": {
"name": "Sheyu Li"
}
},
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as",
"valueMarkdown": "Diabetes treatment medication [Database Entry: FHIR Group Resource]. Contributors: Sheyu Li [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 265092. Revised 2024-11-16. Available at: https://fevir.net/resources/Group/265092. Computable resource at: https://fevir.net/resources/Group/265092#json."
},
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
"valueCodeableConcept": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
"code": "active",
"display": "Active"
}
]
}
}
],
"url": "https://fevir.net/resources/Group/265092",
"identifier": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0203",
"code": "ACSN",
"display": "Accession ID"
}
],
"text": "FEvIR Object Identifier"
},
"system": "https://fevir.net/FOI",
"value": "265092",
"assigner": {
"display": "Computable Publishing LLC"
}
}
],
"title": "Diabetes treatment medication",
"status": "active",
"publisher": "Computable Publishing LLC",
"contact": [
{
"telecom": [
{
"system": "email",
"value": "support@computablepublishing.com"
}
]
}
],
"description": "SGLT-2 inhibitors, GLP-1 receptr agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, thiazolidinediones, sulfonylureas, metformin, α-glucosidase inhibitors, meglitinides, insulins, dual GIP/GLP-1 receptor agonists, or non-steroidal mineralocorticoid receptor antagonists",
"copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"membership": "conceptual",
"combinationMethod": "any-of",
"characteristic": [
{
"code": {
"text": "Drug class"
},
"valueCodeableConcept": {
"text": "SGLT-2 inhibitor"
},
"exclude": false,
"description": "SGLT-2 inhibitors"
},
{
"code": {
"text": "Drug class"
},
"valueCodeableConcept": {
"text": "GLP-1 receptr agonist"
},
"exclude": false,
"description": "GLP-1 receptr agonists"
},
{
"code": {
"text": "Drug class"
},
"valueCodeableConcept": {
"text": "DPP-4 inhibitor"
},
"exclude": false,
"description": "DPP-4 inhibitors"
},
{
"code": {
"text": "Drug class"
},
"valueCodeableConcept": {
"text": "thiazolidinedione"
},
"exclude": false,
"description": "thiazolidinediones"
},
{
"code": {
"text": "Drug class"
},
"valueCodeableConcept": {
"text": "sulfonylurea"
},
"exclude": false,
"description": "sulfonylureas"
},
{
"code": {
"text": "Drug class"
},
"valueCodeableConcept": {
"text": "metformin"
},
"exclude": false,
"description": "metformin"
},
{
"code": {
"text": "Drug class"
},
"valueCodeableConcept": {
"text": "α-glucosidase inhibitor"
},
"exclude": false,
"description": "α-glucosidase inhibitors"
},
{
"code": {
"text": "Drug class"
},
"valueCodeableConcept": {
"text": "meglitinide"
},
"exclude": false,
"description": "meglitinides"
},
{
"code": {
"text": "Drug class"
},
"valueCodeableConcept": {
"text": "insulin"
},
"exclude": false,
"description": "insulins"
},
{
"code": {
"text": "Drug class"
},
"valueCodeableConcept": {
"text": "dual GIP/GLP-1 receptor agonist"
},
"exclude": false,
"description": "dual GIP/GLP-1 receptor agonists"
},
{
"code": {
"text": "Drug class"
},
"valueCodeableConcept": {
"text": "non-steroidal mineralocorticoid receptor antagonist"
},
"exclude": false,
"description": "non-steroidal mineralocorticoid receptor antagonists"
}
]
}